Stt3b-cdg
Description
STT3B-CDG is a form of congenital disorders of N-linked glycosylation characterized by intrauterine growth retardation, microcephaly, failure to thrive, developmental delay, intellectual disability, hypotonia, seizures, optic nerve atrophy and respiratory difficulties. Genital abnormalities (micropenis, hypoplastic scrotum, undescended testes) have also been reported. STT3B-CDG is caused by mutations in the gene STT3B (3p24.1).
Clinical Features
Top most frequent phenotypes and symptoms related to Stt3b-cdg
- Intellectual disability
- Seizures
- Global developmental delay
- Generalized hypotonia
- Microcephaly
- Failure to thrive
- Cryptorchidism
- Feeding difficulties
- Intrauterine growth retardation
- Optic atrophy
And another 7 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Based on the latest data available there are 1 published cases of STT3B-CDG in Europe.— No data available about the known clinical features onset.
Alternative names
Stt3b-cdg Is also known as cdg syndrome type ix, congenital disorder of glycosylation type ix, cdg1x, carbohydrate deficient glycoprotein syndrome type ix, cdg-ix, congenital disorder of glycosylation type 1x.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Stt3b-cdg Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Congenital disorders of glycosylation (NGS panel for 39 genes).
By CGC Genetics (Portugal).
SLC35A1, SLC35A2, SSR4, COG5, ALG9, NGLY1, ALG1, COG4, COG6, COG7, COG8, ALG12, SLC35C1, ALG3, ALG6, ALG2, ALG8, DOLK, MOGS, SRD5A3 , (...)
View the complete list with 19 more genes
Specificity
3 %
Genes
100 % |
Osteopetrosis, autosomal recessive 2 (sequence analysis of TNFSF11 gene).
By CGC Genetics (Portugal).
SSR4, NGLY1, STT3B, STT3A
Specificity
25 %
Genes
100 % |
Congenital disorder of glycosylation type Ix (sequence analysis of STT3B gene).
By CGC Genetics (Portugal).
STT3B
Specificity
100 %
Genes
100 % |
Congenital Disorders of Glycosylation Sequencing Panel with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
SLC35A1, SLC35A2, SSR4, COG5, ALG9, NGLY1, TMEM199, ALG1, ATP6V0A2, COG4, COG6, COG7, COG8, ALG12, SLC35C1, DHDDS, SLC39A8, GMPPA, ALG3, ALG6 , (...)
View the complete list with 30 more genes
Specificity
2 %
Genes
100 % |
Mental retardation - different panels.
By Institute of Human Genetics Uniklinik RWTH Aachen (Germany).
RGS7, RIT1, RMRP, BCS1L, RPL10, RPS6KA3, RRAS, SALL1, SC5D, ATXN10, BLM, SCN1A, SCN2A, SCN8A, SCO2, AIMP1, SDCCAG8, SDHA, SDHB, SGSH , (...)
View the complete list with 845 more genes
Specificity
1 %
Genes
100 % |
Congenital Disorders of Glycosylation (CDG).
By MGZ Medical Genetics Center (Germany).
SLC35A1, SLC35A2, SSR4, COG5, ALG9, ALG1, COG4, COG6, COG7, COG8, ALG12, SLC35C1, DHDDS, GMPPA, ALG3, ALG6, ALG8, DOLK, MOGS, SRD5A3 , (...)
View the complete list with 18 more genes
Specificity
3 %
Genes
100 % |
Congenital Disorders of Glycosylation Panel.
By Blueprint Genetics (Finland).
SEC23B, SLC35A1, SLC35A2, SSR4, COG5, ALG9, NGLY1, ALG1, ATP6V0A2, COG4, COG6, COG7, COG8, ALG12, SLC35C1, B3GLCT, DHDDS, GMPPA, ALG3, ALG6 , (...)
View the complete list with 27 more genes
Specificity
3 %
Genes
100 % |
Comprehensive Metabolism Panel.
By Blueprint Genetics (Finland).
BCS1L, CNNM2, RYR1, CNNM4, SCN4A, SEC23B, SGSH, SI, SLC40A1, SLC12A3, SLC16A1, SLC17A5, SLC22A5, SLC25A1, SLC25A13, SLC25A15, SLC25A3, SLC25A4, SLC2A1, SLC2A2 , (...)
View the complete list with 411 more genes
Specificity
1 %
Genes
100 % |
You can get up to 0 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like PORTAL HYPERTENSION, NONCIRRHOTIC; NCPH PARKES WEBER SYNDROME EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53 FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1 PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7